Who invested in Regend Therapeutics?
Regend Therapeutics's investors include Shenzhen Capital Group Co..
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 9 months ago
Funding summaryUpdated 26 Oct 2026
$51Mraised across 1 round since 2026, from 1 source
Regend Therapeutics's investors include Shenzhen Capital Group Co..
Regend Therapeutics has raised $51M across 1 round since 2026.
Regend Therapeutics's most recent round was a Series C of $51M in Feb 2026.
Its most recent round, $51M in Feb 2026, is also its largest on record.
Regend Therapeutics's first round on record, in Feb 2026, was backed by Shenzhen Capital Group Co..
Regend Therapeutics's latest named round is a Series C, in Feb 2026.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.